[ad_1]
Posted in:
In its recommendation, the High Authority for Health said that people who have recovered from Covid-19 “have already developed immune memory during infection. Thus, a single dose will act as a booster”. France has become the first country in the world to issue such a recommendation.
“Give only one dose to those recovering from the epidemic” is what the French health authorities recommended on Friday concerning Doses of the Covid-19 vaccine This is for people “who have already been infected” with the virus, becoming the first country to issue such a recommendation.
The Supreme Health Authority says in its recommendation, which is still supposed to get government approval, that people who have recovered from Covid-19 “have already developed immune memory during infection. Therefore, a single dose will act as a booster. “
للمزيد- What do the Corona virus vaccine “effectiveness” rates mean?
On the other hand, the authority recommended to wait “a period of more than three months” after the infection “and it is advised of six months” before receiving this single dose.
“So far, no country has made a clear decision to vaccinate with a single dose of people who contracted Covid-19 before vaccination,” she said.
In recent days, this solution has been discussed in several studies conducted in the United States and Italy that have not yet been evaluated by other scientists.
In addition to the health benefits, the researchers who conducted the research indicated that giving a single dose to people who previously had the disease could save doses amidst supply shortages.
The French government generally follows the recommendations of the Supreme Health Council. But he estimated at the end of January that it was not possible to increase the time between the two doses of the Pfizer vaccine, contrary to the recommendation issued a few days earlier by the Supreme Committee.
The health authorities are betting a lot on the progress of the vaccination campaign to face a fragile epidemic situation on a long way to go: Thursday, 2,135.33 people had received at least one dose of the vaccine in France, of which 535,775 had. received two doses.
Since the start of the epidemic, there have been 3.4 million infections in France. But it’s likely that more people were infected with the virus in the first wave when testing was not widely available.
The three vaccines currently licensed in the European Union are Pfizer / Biontec, Moderna and AstraZeneca / Oxford, and require two doses to be fully effective in people who have never had the disease.
The European Medicines Agency is currently studying the single-dose Johnson & Johnson vaccine.
France 24 / AFP
Source link
